NCTY
The9 LTD
$4.73
+0.85%
$72.0M
No data for this timeframe.
Vol
Market Cap$72.0M
Cap SizeMicro Cap
Inst. Holders2 funds
Inst. Value$4.0K
Inst. Activity0 buys / 1 sells
Recent Activity
Inst.
MORGAN STANLEY — NEAR_EXIT
627 shares ($4.0K)
Inst.
MORGAN STANLEY — TRIM
25,523 shares ($271.3K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $4.0K | NEAR_EXIT |
| BANK OF AMERICA CORP | $32.00 | — |
2 institutional holders with $4.0K total value (632 shares) as of 2025-Q4. Top holders: MORGAN, BANK. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 627 | $4.0K | 99.2% | NEAR_EXIT -97.5% |
| 2 | BANK OF AMERICA CORP /DE/ | 5 | $32.00 | 0.8% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | NEAR_EXIT | 25,523 | 627 | -97.5% | $4.0K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 52,647 | 25,523 | -51.5% | $271.3K | 2025-Q3 |
| UBS Group AG | TRIM | 36,664 | 23,060 | -37.1% | $245.1K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 137,404 | 52,647 | -61.7% | $409.6K | 2025-Q2 |
| UBS Group AG | ADD | 18,977 | 36,664 | +93.2% | $285.2K | 2025-Q2 |
| CITADEL ADVISORS LLC | NEW | — | 29,398 | — | $441.3K | 2025-Q1 |
| UBS Group AG | DOUBLED | 928 | 18,977 | +1944.9% | $284.8K | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 38 | 154,741 | +407113.2% | $2.2M | 2024-Q4 |
| UBS Group AG | DOUBLED | 116 | 928 | +700.0% | $13.5K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2014-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.